Treatment-Diagnosis Alignment

Analyze medication treatments against documented diagnoses

5

Total Treatments

3

Aligned

2

Gaps Identified

High

DRG Impact

Active Medications

  • Furosemide

    40mg IV BID

    Loop Diuretic

  • Metformin

    1000mg PO BID

    Antidiabetic

  • Tiotropium

    18mcg INH Daily

    Bronchodilator

  • Sevelamer

    800mg PO TID

    Phosphate Binder

  • Epoetin alfa

    10000 units SC Weekly

    ESA

  • Lisinopril

    20mg PO Daily

    ACE Inhibitor

  • Amlodipine

    10mg PO Daily

    CCB

Treatment Alignment Analysis

  • IV Furosemide 40mg BID

    Documented

    Expected: Heart Failure

    Documented as: I50.9

  • Metformin 1000mg BID

    Documented

    Expected: Type 2 Diabetes Mellitus

    Documented as: E11.9

  • Tiotropium (Spiriva) inhaler

    Documented

    Expected: COPD

    Documented as: J44.9

  • Sevelamer 800mg TID

    Gap

    Expected: Chronic Kidney Disease

    Suggested codes:

    N18.3N18.4N18.5

  • Epoetin alfa injection

    Gap

    Expected: Anemia of CKD

    Suggested codes:

    D63.1

Documentation Gap Details

  • Chronic Kidney Disease

    Confidence: 92%

    Treatment: Sevelamer 800mg TID

    Clinical Rationale: Sevelamer is a phosphate binder used exclusively in CKD patients to manage hyperphosphatemia

    Suggested Query:

    Patient is on Sevelamer (phosphate binder) indicating CKD. Please document the CKD stage and any related complications.

  • Anemia of Chronic Kidney Disease

    Confidence: 88%

    Treatment: Epoetin alfa injection

    Clinical Rationale: Erythropoiesis-stimulating agent typically prescribed for anemia secondary to CKD

    Suggested Query:

    Patient is receiving Epoetin alfa suggesting anemia of CKD. Please document the diagnosis and current hemoglobin level.